1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with reserpine in 4 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (reserpine) | Trials (reserpine) | Recent Studies (post-2010) (reserpine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 15,546 | 223 | 436 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | reserpine (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.7875 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.2092 | |
| Quinolone resistance protein NorA | Staphylococcus aureus | 8.5429 | |
| Mu-type opioid receptor | Homo sapiens (human) | 4.152 | |
| Chromaffin granule amine transporter | Homo sapiens (human) | 0.05 | |
| Synaptic vesicular amine transporter | Rattus norvegicus (Norway rat) | 0.0034 | |
| Synaptic vesicular amine transporter | Homo sapiens (human) | 0.0147 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamata, K; Kasuya, Y; Mori, T; Shigenobu, K | 1 |
| Criscuoli, M; Subissi, A | 1 |
| Chignard, M; Lefort, J; Medeiros, MC; Vargaftig, BB; Wal, F | 1 |
| Altenburg, SP; Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; Martins, MA; Silva, PM; Tibiriçá, EV | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and reserpine
| Article | Year |
|---|---|
Platelet-activating factor: lack of direct action on guinea pig myocardium and possible transmitter release from cardiac sympathetic nerve endings at high concentrations.
Topics: Action Potentials; Animals; Electrophysiology; Guinea Pigs; Heart; In Vitro Techniques; Isoproterenol; Lysophosphatidylcholines; Male; Myocardium; Neurons; Neurotransmitter Agents; Papillary Muscles; Platelet Activating Factor; Reserpine; Sotalol; Sympathetic Nervous System | 1989 |
Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice.
Topics: Adrenal Cortex Hormones; Adrenal Medulla; Adrenalectomy; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Catecholamines; Cold Temperature; Drug Interactions; Male; Mice; Platelet Activating Factor; Receptors, Adrenergic, beta; Reserpine; Stress, Physiological; Urethane | 1988 |
Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions.
Topics: Animals; Blood Platelets; Bronchi; Guinea Pigs; Platelet Activating Factor; Platelet Aggregation; Reserpine; Stereoisomerism; Sulfinpyrazone | 1982 |
Adrenergic modulation of the blood neutrophilia induced by platelet activating factor in rats.
Topics: Adrenalectomy; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bone Marrow; Bone Marrow Cells; Leukocyte Count; Male; Neutrophils; Platelet Activating Factor; Rats; Rats, Wistar; Reserpine; Sympathetic Nervous System | 1994 |